Literature DB >> 3307442

Tumor cell growth fraction in Hodgkin's disease.

J Gerdes, J Van Baarlen, S Pileri, R Schwarting, J A Van Unnik, H Stein.   

Abstract

The growth fraction of tumor cells was studied in 45 cases of Hodgkin's disease by means of a recently developed double immunostaining technique using monoclonal antibody Ki-1, which reacts selectively with Hodgkin and Reed-Sternberg cells in tissues affected by Hodgkin's disease, and antibody Ki-67, which recognizes a cell proliferation-associated nuclear antigen. The medians of the growth fractions of the tumor cells in all histologic subtypes of Hodgkin's disease varied between 78% and 83%. In none of the cases investigated did we find a growth fraction below 50%. Furthermore, mononucleated Hodgkin cells as well as multi-nucleated Reed-Sternberg cells showed a similar Ki-67 labeling index, indicating that both tumor cell types belong to the proliferating pool of this malignancy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307442      PMCID: PMC1899675     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue.

Authors:  J Gerdes; R Schwarting; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  Kinetics of lymphocytes in Hodgkin's disease.

Authors:  P Schick; F Trepel; H Theml; S Benedek; P Trumpp; W Kaboth; H Begemann; T M Fliedner
Journal:  Blut       Date:  1973-10

Review 3.  Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors:  F Valeriote; L van Putten
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Hodgkin's disease cell lines: characteristics and biological activities.

Authors:  V Diehl; H Burrichter; M Schaadt; H H Kirchner; C Fonatsch; H Stein; J Gerdes; W Heit; A Ziegler
Journal:  Haematol Blood Transfus       Date:  1983

6.  Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells.

Authors:  U Schwab; H Stein; J Gerdes; H Lemke; H Kirchner; M Schaadt; V Diehl
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

7.  [DNA-synthesis in blood lymphocytes in malignant lymphogranuloma].

Authors:  C Huber; H Huber; F Schmalzl; B Lederer; D Bütterich; H Braunsteiner
Journal:  Acta Haematol       Date:  1970       Impact factor: 2.195

8.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

9.  Production of colony-stimulating factors by Hodgkin cell lines.

Authors:  H Burrichter; W Heit; M Schaadt; H Kirchner; V Diehl
Journal:  Int J Cancer       Date:  1983-03-15       Impact factor: 7.396

10.  Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.

Authors:  H Stein; J Gerdes; U Schwab; H Lemke; D Y Mason; A Ziegler; W Schienle; V Diehl
Journal:  Int J Cancer       Date:  1982-10-15       Impact factor: 7.396

View more
  15 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 2.  Proliferation indices in malignant lymphomas.

Authors:  J Crocker
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

Review 3.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 4.  Comments on Hodgkin's disease: the Sternberg-Reed cell by P. Bucsky.

Authors:  H Stein
Journal:  Blut       Date:  1988-09

5.  Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.

Authors:  N M Jiwa; P Kanavaros; P van der Valk; J M Walboomers; A Horstman; W Vos; H Mullink; C J Meijer
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

6.  Epstein-Barr virus infection correlates with the expression of COX-2, p16(INK4A) and p53 in classic Hodgkin lymphoma.

Authors:  Suhail Al-Salam; Aktham Awwad; Manjusha Sudhadevi; Sayel Daoud; Nico J D Nagelkerke; Antonio Castella; S M Chong; Mouied Alashari
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

7.  Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

Authors:  Stephan Mathas; Michael Hinz; Ioannis Anagnostopoulos; Daniel Krappmann; Andreas Lietz; Franziska Jundt; Kurt Bommert; Fatima Mechta-Grigoriou; Harald Stein; Bernd Dörken; Claus Scheidereit
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

8.  Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.

Authors:  C Schmid; L Pan; T Diss; P G Isaacson
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

9.  Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.

Authors:  H Spiegel; H Herbst; G Niedobitek; H D Foss; H Stein
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

10.  The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.

Authors:  A Claviez; M Tiemann; J Peters; H Kreipe; R Schneppenheim; R Parwaresch
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.